Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA Cancer J Clin. 2015. [PMID: 26513636] doi:10.3322/caac.21320Gaylis FD, Choi J, Kader AK. Trends in Metastatic Breast a...
Primary tumor resection for metastatic breast cancer (MBC) has demonstrated a survival advantage, however, not all patients with MBC benefit from surgery. The purpose of this study was to develop a predictive model to select patients with MBC who are most likely to benefit from surgery at the ...
L. et al. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2, pky062 (2018). Article PubMed Central PubMed Google Scholar Howlader, N. et al. (eds.) in SEER Cancer Statistics Review, 1975–2016 1423–1437 ...
Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin, 71 (3) (2021), pp. 209-249 CrossrefGoogle Scholar 2 W.F. Anderson, I. Jatoi, J. Tse, et al. Male breast cancer: a population-based comparison with...
The primary objective of the present study was to evaluate the prognostic impact of BMI at MBC diagnosis on OS of women with metastatic breast cancer. The other objectives were to assess patient characteristics by BMI category, first-line progression-free survival (PFS), and impact of BMI on ...
Metastatic (Stage IV) Breast Cancer / Advanced/Metastatic Breast Cancer / Metastatic Breast Cancer / Metastatic Breast Cancers / Breast cancer metastatic / Carcinoma breast stage IV / Breast carcinoma NOS stage IV / Breast carcinoma stage IV / Breast cancer stage IV / Breast cancer NOS stage IV...
Descriptive statistics and regression models were used. Results: A total of 3,556 everolimus users were identified (median age of 60 years; median days of use, 112). The initial prescribed dose was 10 mg in 74.8% of the patients. Compared with the initial dose, 23.5% of patients had a ...
Breast cancer can recur months to decades after an initial diagnosis and treatment. The mechanisms that control tumor cell dormancy remain poorly understood, making it difficult to predict which patients will recur and thus benefit from more rigorous scr
Cancer statistics. CA Cancer J. Clin. 71, 7–33 (2021). Article Google Scholar Bertucci, F. et al. Genomic characterization of metastatic breast cancers. Nature 569, 560–564 (2019). Article CAS Google Scholar Aftimos, P. et al. Genomic and transcriptomic analyses of breast cancer ...
Thus, metastases to the bone are at least as frequent in breast cancer as in lung cancer. The simplest explanation to the above presented statistics is that bone metastasis is not primarily seeded from the lung. Therefore we will have a separate direct dissemination paths from the primary to ...